Free Trial

Teleflex (TFX) Competitors

Teleflex logo
$178.16 +3.37 (+1.93%)
(As of 12/20/2024 05:31 PM ET)

TFX vs. DXCM, STE, PODD, HOLX, BAX, GMED, MASI, ITGR, IART, and ATRC

Should you be buying Teleflex stock or one of its competitors? The main competitors of Teleflex include DexCom (DXCM), STERIS (STE), Insulet (PODD), Hologic (HOLX), Baxter International (BAX), Globus Medical (GMED), Masimo (MASI), Integer (ITGR), Integra LifeSciences (IART), and AtriCure (ATRC). These companies are all part of the "health care equipment" industry.

Teleflex vs.

DexCom (NASDAQ:DXCM) and Teleflex (NYSE:TFX) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, community ranking, dividends, analyst recommendations, earnings, media sentiment, institutional ownership and profitability.

DexCom has a net margin of 17.22% compared to Teleflex's net margin of 7.85%. DexCom's return on equity of 31.40% beat Teleflex's return on equity.

Company Net Margins Return on Equity Return on Assets
DexCom17.22% 31.40% 10.58%
Teleflex 7.85%14.19%8.53%

97.8% of DexCom shares are held by institutional investors. Comparatively, 95.6% of Teleflex shares are held by institutional investors. 0.3% of DexCom shares are held by insiders. Comparatively, 1.4% of Teleflex shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

DexCom has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DexCom$3.95B7.91$541.50M$1.6747.93
Teleflex$3.03B2.73$356.33M$5.0335.42

In the previous week, DexCom had 4 more articles in the media than Teleflex. MarketBeat recorded 15 mentions for DexCom and 11 mentions for Teleflex. DexCom's average media sentiment score of 0.85 beat Teleflex's score of 0.52 indicating that DexCom is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DexCom
7 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Teleflex
2 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive

DexCom received 449 more outperform votes than Teleflex when rated by MarketBeat users. Likewise, 71.72% of users gave DexCom an outperform vote while only 59.19% of users gave Teleflex an outperform vote.

CompanyUnderperformOutperform
DexComOutperform Votes
974
71.72%
Underperform Votes
384
28.28%
TeleflexOutperform Votes
525
59.19%
Underperform Votes
362
40.81%

DexCom currently has a consensus price target of $98.00, indicating a potential upside of 22.44%. Teleflex has a consensus price target of $252.50, indicating a potential upside of 41.73%. Given Teleflex's higher probable upside, analysts clearly believe Teleflex is more favorable than DexCom.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DexCom
0 Sell rating(s)
6 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.72
Teleflex
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.57

DexCom has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500. Comparatively, Teleflex has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500.

Summary

DexCom beats Teleflex on 15 of the 19 factors compared between the two stocks.

Get Teleflex News Delivered to You Automatically

Sign up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TFX vs. The Competition

MetricTeleflexSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$8.27B$4.34B$5.12B$19.18B
Dividend Yield0.77%41.46%4.91%3.59%
P/E Ratio35.4225.3791.3441.28
Price / Sales2.7345.681,116.5917.59
Price / Cash9.5743.4542.6421.28
Price / Book1.897.364.795.32
Net Income$356.33M$13.64M$120.07M$989.88M
7 Day Performance-1.10%-2.80%-1.89%-3.54%
1 Month Performance-6.48%0.56%11.45%-3.68%
1 Year Performance-29.14%41.87%30.61%12.14%

Teleflex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TFX
Teleflex
4.8981 of 5 stars
$178.16
+1.9%
$252.50
+41.7%
-28.0%$8.27B$3.03B35.4214,500Analyst Forecast
High Trading Volume
DXCM
DexCom
4.9166 of 5 stars
$76.47
-0.9%
$98.00
+28.2%
-31.4%$29.87B$3.95B46.229,600
STE
STERIS
4.9335 of 5 stars
$212.73
-0.7%
$262.50
+23.4%
-3.5%$21.00B$5.14B48.9118,179Positive News
PODD
Insulet
4.256 of 5 stars
$264.61
-1.8%
$267.44
+1.1%
+28.2%$18.56B$1.70B46.123,000Positive News
HOLX
Hologic
4.7224 of 5 stars
$72.81
-1.1%
$89.50
+22.9%
+1.9%$16.52B$4.03B22.147,063Analyst Forecast
BAX
Baxter International
4.5387 of 5 stars
$29.46
-2.8%
$40.45
+37.3%
-23.6%$15.04B$15.06B149.2060,000Options Volume
News Coverage
GMED
Globus Medical
4.8825 of 5 stars
$82.17
-0.3%
$92.18
+12.2%
+59.4%$11.19B$2.48B122.675,000Analyst Forecast
Analyst Revision
MASI
Masimo
3.5649 of 5 stars
$176.71
+0.3%
$170.67
-3.4%
+49.0%$9.46B$2.04B121.485,200Analyst Forecast
ITGR
Integer
2.8643 of 5 stars
$138.73
+0.0%
$145.44
+4.8%
+36.4%$4.65B$1.71B43.0310,500Positive News
IART
Integra LifeSciences
3.9777 of 5 stars
$24.08
+0.2%
$23.00
-4.5%
-49.5%$1.86B$1.56B-267.003,946Positive News
ATRC
AtriCure
3.3562 of 5 stars
$31.79
+0.4%
$42.00
+32.1%
-10.9%$1.55B$447.57M-38.161,200Analyst Forecast

Related Companies and Tools


This page (NYSE:TFX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners